Gozellix®

telix-pharmaceuticals-reports-strong-revenue-growth-eyes-future-expansion

Telix Pharmaceuticals Reports Strong Revenue Growth, Eyes Future Expansion

Editorial 20 January, 2026

Shares in Telix Pharmaceuticals Ltd (ASX: TLX) are expected to attract attention following the...

first-u-s-patient-dosed-in-groundbreaking-prostate-cancer-study

First U.S. Patient Dosed in Groundbreaking Prostate Cancer Study

Editorial 16 January, 2026

Telix Pharmaceuticals Limited has announced a significant milestone in prostate cancer diagnosis with the...